Novavax incurred a third-quarter 2024 loss of 76 cents per share, narrower than the Zacks Consensus Estimate of a loss of 87 cents. In the year-ago quarter, the company reported a loss of $1.26 per ...

Issued on behalf of Oncolytics Biotech Inc. "With positive BRACELET-1 results, we have two randomized phase two studies confirming pelareorep's potential in HR+/HER2- metastatic breast cancer,” said ...

India’s Supreme Court released a ruling on Wednesday finding that the country’s authorities cannot use demolition of properties as punishment for those accused or convicted of crimes. It set stringent ...

We read every day so you don't have to. Sign up for CNN Business' nightly newsletter for the top stories you need to know.